Tang Gale L, Fillinger Mark F, Matsumura Jon S
Division of Vascular Surgery, Northwestern University Feinberg School of Medicine, Chicago, IL 60611, USA.
J Vasc Surg. 2009 Jun;49(6):1409-15. doi: 10.1016/j.jvs.2009.02.209.
The original abdominal Excluder (W.L. Gore & Associates, Flagstaff, Ariz) endoprosthesis has been associated with late aneurysm sac expansion over time from transgraft ultrafiltration of serous fluid. This has been treated by relining the graft with original or low-permeability components. We asked whether additional component overlap of the original graft material resulting from proximal or distal extensions placed at the time of initial repair would influence the rate of late aneurysm sac expansion in the absence of endoleak.
Computed tomography (CT) scans from subjects (n = 120) receiving the original endoprosthesis from the Excluder pivotal trial were measured for total distance of original graft overlap (including contralateral gate, proximal extension, or distal extension overlap) based on reformatted CT scans. This was compared to change in aneurysm sac diameter and volume (as measured in independent laboratories) at the latest time point available. Patients were omitted if they were missing CT scan data (n = 10), their graft was explanted for endoleak (n = 2), they underwent an intervention for endoleak and did not have diameters available after their intervention (n = 3), or if they had a continued endoleak that could account for an increase in aneurysm sac diameter (n = 11). This left 27 patients with more overlapping components than the required contralateral limb/gate overlap (mean follow-up time 40.6 +/- 17.0 months) and 67 patients with required gate overlap (mean follow-up time 46.2 +/- 15.9 months).
Subjects with increased component overlap (mean overlap 87.1 mm +/- 57.4 mm) were not protected from aneurysm sac expansion when compared to those with the minimum required gate overlap (mean overlap 31.2 mm +/- 3.4 mm). There was no association of total distance of overlap with aneurysm sac size change by diameter or volume (r(2) = 0.00034, P = .86 for diameter and r(2) = 0.0019, P = .68 for volume). Increasing percentage of overlap within the aneurysm sac was likewise not associated with aneurysm sac decrease in diameter (r(2) = 0.0028, P = .61). Few patients had large percentages of original graft overlap (mean 26.2% +/- 14.1% for the increased overlap group and 18.6% +/- 5.5% for the required overlap group, P = .0097).
Partial graft overlap involving multiple original components from proximal and distal extensions is not protective against aneurysm sac expansion due to transgraft ultrafiltration. This suggests that transgraft ultrafiltration is not impeded by having partial double layers of original material. All patients who received the original Excluder and have late aneurysm sac expansion in the absence of endoleak should have as complete relining as feasible with low permeability components if sac shrinkage is the surrogate goal.
最初的腹部封堵器(W.L. Gore & Associates公司,亚利桑那州弗拉格斯塔夫)内置假体随着时间推移,因浆液经移植物超滤导致动脉瘤囊晚期扩张。对此采用使用原始或低渗透性组件对移植物进行内衬处理。我们探讨了在初始修复时放置的近端或远端延伸导致原始移植物材料额外的组件重叠,在无内漏情况下是否会影响动脉瘤囊晚期扩张率。
对接受Excluder关键试验中最初内置假体的受试者(n = 120)的计算机断层扫描(CT)进行测量,根据重新格式化的CT扫描测量原始移植物重叠的总距离(包括对侧门、近端延伸或远端延伸重叠)。将其与在可获得的最新时间点动脉瘤囊直径和体积的变化(在独立实验室测量)进行比较。如果患者缺少CT扫描数据(n = 10)、其移植物因内漏而被取出(n = 2)、他们因内漏接受了干预且干预后没有可用直径(n = 3),或者他们存在持续内漏且可解释动脉瘤囊直径增加(n = 11),则将这些患者排除。这留下了27例组件重叠超过所需对侧肢体/门重叠的患者(平均随访时间40.6 +/- 17.0个月)和67例具有所需门重叠的患者(平均随访时间46.2 +/- 15.9个月)。
与具有最小所需门重叠(平均重叠31.2 mm +/- 3.4 mm)的受试者相比,组件重叠增加的受试者(平均重叠87.1 mm +/- 57.4 mm)并不能防止动脉瘤囊扩张。重叠总距离与动脉瘤囊直径或体积的大小变化无关联(直径方面r(2) = 0.00034,P = 0.86;体积方面r(2) = 0.0019,P = 0.68)。动脉瘤囊内重叠百分比的增加同样与动脉瘤囊直径减小无关(r(2) = 0.0028,P = 0.61)。很少有患者原始移植物重叠百分比大(重叠增加组平均为26.2% +/- 14.1%,所需重叠组平均为18.6% +/- 5.5%,P = 0.0097)。
涉及近端和远端延伸的多个原始组件的部分移植物重叠不能防止因移植物超滤导致的动脉瘤囊扩张。这表明原始材料的部分双层结构不会阻碍移植物超滤。如果以囊缩小为替代目标,所有接受最初Excluder且在无内漏情况下出现动脉瘤囊晚期扩张的患者应尽可能用低渗透性组件进行完整内衬处理。